Percentage of participants who decline participation because of randomization.
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 0 | |
| CARE-Well App | 0 |
Last reviewed · How we verify
Translating a Dementia Caregiver Intervention Into a Mobile Application
NA trial testing CARE-Well App in Dementia in 40 participants. Completed in 30 May 2022.
| Lead sponsor | Rhode Island Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 13 January 2020 |
| Primary completion | 30 May 2022 |
| Estimated completion | 30 May 2022 |
| Sites | 2 locations across United States |
Rhode Island Hospital
18 and older, any sex, with Dementia or Alzheimer Disease. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Percentage of participants who decline participation because of randomization.
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 0 | |
| CARE-Well App | 0 |
Percentage of participants enrolled and who remain enrolled for the duration of the study.
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 18 | |
| CARE-Well App | 16 |
Percentage of participants who used the internet links or the app for the 3-month intervention period.
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 18 | |
| CARE-Well App | 16 |
Percentage of participants who completed assessments at baseline and follow-up within two weeks of enrollment or completion of the study.
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 18 | |
| CARE-Well App | 16 |
Percentage of participants who completed the intervention.
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 18 | |
| CARE-Well App | 16 |
Percentage of participants in a subset of caregivers (10 from each group) interested in continuing to use tablet/App use after formal trial as an estimate of sustainability.
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 10 | |
| CARE-Well App | 10 |
Percentage of participants satisfied or very satisfied with App technology.
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 13 | |
| CARE-Well App | 12 |
Percentage of participants satisfied or very satisfied with App content.
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 13 | |
| CARE-Well App | 11 |
Depression scale; 0-30 points; higher scores indicate worse outcome.
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 13.29 | ± 7.88 |
| CARE-Well App | 13.94 | ± 12.19 |
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 16.71 | ± 8.36 |
| CARE-Well App | 17.38 | ± 11.67 |
Caregiver burden scale; 0-88 points; higher scores indicate worse outcome.
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 55.53 | ± 9.82 |
| CARE-Well App | 56.56 | ± 14.40 |
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 58.11 | ± 10.93 |
| CARE-Well App | 57.56 | ± 13.22 |
Caregiver reaction to problem behaviors; range 0-96 Higher scores indicate worse outcomes.
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 22.88 | ± 7.90 |
| CARE-Well App | 22.00 | ± 8.61 |
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 18.10 | ± 10.56 |
| CARE-Well App | 11.56 | ± 16.91 |
Caregiver desire to institutionalize care recipient; 0-7 points; high scores indicate worse outcome (or stronger desire to institutionalize).
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 0.82 | ± 1.24 |
| CARE-Well App | 1.38 | ± 1.45 |
| Group | Value | 95% CI |
|---|---|---|
| Internet Links | 1.12 | ± 1.54 |
| CARE-Well App | 1.94 | ± 2.29 |
The overall goal of this development project is to combine elements of two efficacious interventions into a mobile health (mHealth) App for informal dementia caregivers. The investigators will conduct a 3-month feasibility trial of the newly-developed CARE-Well App in 40 dementia caregivers to establish acceptability and feasibility of the intervention, study procedures, and outcome measures.
1 peer-reviewed publication reference this trial (live from Europe PMC):
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04330482.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing